Detecting and monitoring longitudinal pathological and clinical changes of Alzheimer's disease using plasma p ‐Tau217

Abstract

Background: Phosphorylated tau217 ( p ‐tau217) are promising blood biomarkers for evaluating Alzheimer's disease (AD) neuropathology. This study investigated the performance of leading commercial p ‐tau217 assays in detecting and monitoring AD‐relevant processes.